testosterone

Between a rock and a hard place

Pharma

Clarus' fate in limbo as lead drug Jatenzo sputters

Some two years after braving the pandemic to launch its oral testosterone replacement tablet Jatenzo, Clarus Therapeutics is in dire straits.

Fraiser Kansteiner Aug 19, 2022 10:35am

Antares, Lipocine win FDA nod for oral testosterone med

Mar 29, 2022 11:42am

FTC building

After dropping case, FTC urges for new legislation

Aug 2, 2021 10:54am

railroad

Drugmakers blaze a path for new therapy launches during COVID-19

Jun 18, 2020 11:00am

FDA

Antares wins FDA nod for testosterone drug Xyosted

Oct 1, 2018 11:27am

contract

AbbVie nears settlement covering 4,000-plus AndroGel cases

Sep 11, 2018 10:35am